The Europe in-vitro diagnostics market is expected to grow from US$ 22,616.55 million in 2022 to US$ 34,247.12 million by 2030. It is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Rise in the Demand for In-Vitro Diagnostics During COVID-19 Pandemic Fuels Europe In-Vitro Diagnostics Market

The COVID-19 pandemic significantly boosted the demand for in-vitro diagnostics (IVDs) in Europe. IVDs, including immunoassays and molecular assays, played a crucial role in diagnosing infectious diseases. Diagnostics companies actively focused on rapid advancements in their offerings to manage COVID-19. Furthermore, regulatory bodies implemented temporary changes to their standards, facilitating the introduction of new IVDs during the pandemic. This led to a surge in demand for molecular diagnostics and immunoassays, further amplified by government initiatives. Many companies also expanded their IVD manufacturing product lines.  

In June 2021, the British In Vitro Diagnostics Association (BIVDA) launched "The Digital Revolution" strategy to foster breakthroughs in in-vitro diagnostics during the COVID-19 pandemic. Subsequently, in July 2022, BioGX announced the CE-marked launch of a three-gene point-of-care (POC) multiplex COVID-19 test on its Pixel platform. Consequently, the COVID-19 pandemic positively impacted the in-vitro diagnostics market due to the escalating need for point-of-care (POC) diagnostics and laboratory testing procedures.  

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00022122

Market Overview

The Europe in-vitro diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The market's growth in this region is driven by increasing awareness of disease diagnosis, a growing elderly population, and technological advancements in in-vitro diagnostics, thereby dominating overall market growth. Germany holds the largest share of the European in-vitro diagnostic (IVD) market, renowned for its innovation capabilities. The German IVD industry benefits from progress in molecular biology, miniaturization, and automation. Germany's "Industrie 4.0" project is driving digitalization, particularly in ICD, with "Lab 4.0" developed for data handling, cloud-based IT solutions, lab and production automation processes, and digital networking.  

The IVD market in Germany experienced a substantial surge in demand during the COVID-19 pandemic. Comprehensive testing was a central element of the German government's health policy strategy to combat the pandemic and protect the population from infection. German-based companies are established innovators in developing molecular tests, as well as high-tech instruments and consumables used in the bioanalysis of molecular information. The development of in-vitro diagnostics through innovative product launches by companies with automation systems in labs propels the in-vitro diagnostics market in Germany.  

Europe In-Vitro Diagnostics Market Segmentation

The Europe in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the Europe in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on technology, the Europe in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on application, the Europe in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Europe in-vitro diagnostics market in 2022.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications